| “Nanoantibiotics”: a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era AJ Huh, YJ Kwon Journal of controlled release 156 (2), 128-145, 2011 | 2227 | 2011 |
| “Combo” nanomedicine: co-delivery of multi-modal therapeutics for efficient, targeted, and safe cancer therapy JA Kemp, MS Shim, CY Heo, YJ Kwon Advanced drug delivery reviews 98, 3-18, 2016 | 490 | 2016 |
| COVID-19 vaccines: The status and perspectives in delivery points of view JY Chung, MN Thone, YJ Kwon Advanced drug delivery reviews 170, 1-25, 2021 | 488 | 2021 |
| Stimuli-responsive polymers and nanomaterials for gene delivery and imaging applications MS Shim, YJ Kwon Advanced drug delivery reviews 64 (11), 1046-1059, 2012 | 451 | 2012 |
| Molecular genetics and emerging therapies for retinitis pigmentosa: Basic research and clinical perspectives MF Dias, K Joo, JA Kemp, SL Fialho, A da Silva Cunha Jr, SJ Woo, ... Progress in retinal and eye research 63, 107-131, 2018 | 430 | 2018 |
| Efficient and targeted delivery of siRNA in vivo MS Shim, YJ Kwon The FEBS journal 277 (23), 4814-4827, 2010 | 401 | 2010 |
| In vivo targeting of dendritic cells for activation of cellular immunity using vaccine carriers based on pH-responsive microparticles YJ Kwon, E James, N Shastri, JMJ Fréchet Proceedings of the National Academy of Sciences 102 (51), 18264-18268, 2005 | 255 | 2005 |
| Enhanced detection of early-stage oral cancer in vivo by optical coherence tomography using multimodal delivery of gold nanoparticles CS Kim, P Wilder-Smith, YC Ahn, LHL Liaw, Z Chen, YJ Kwon Journal of biomedical optics 14 (3), 034008-034008-8, 2009 | 192 | 2009 |
| Cancer nanotechnology: current status and perspectives JA Kemp, YJ Kwon Nano convergence 8 (1), 34, 2021 | 188 | 2021 |
| Aptamers: The “evolution” of SELEX YX Wu, YJ Kwon Methods 106, 21-28, 2016 | 183 | 2016 |
| Enhanced antigen presentation and immunostimulation of dendritic cells using acid-degradable cationic nanoparticles YJ Kwon, SM Standley, SL Goh, JMJ Fréchet Journal of controlled release 105 (3), 199-212, 2005 | 181 | 2005 |
| Good things come in small packages: Overcoming challenges to harness extracellular vesicles for therapeutic delivery D Ingato, JU Lee, SJ Sim, YJ Kwon Journal of controlled release 241, 174-185, 2016 | 180 | 2016 |
| Acid-responsive linear polyethylenimine for efficient, specific, and biocompatible siRNA delivery MS Shim, YJ Kwon Bioconjugate chemistry 20 (3), 488-499, 2009 | 150 | 2009 |
| Controlled delivery of plasmid DNA and siRNA to intracellular targets using ketalized polyethylenimine MS Shim, YJ Kwon Biomacromolecules 9 (2), 444-455, 2008 | 139 | 2008 |
| Before and after endosomal escape: roles of stimuli-converting siRNA/polymer interactions in determining gene silencing efficiency YJ Kwon Accounts of chemical research 45 (7), 1077-1088, 2012 | 125 | 2012 |
| Acid-degradable particles for protein-based vaccines: enhanced survival rate for tumor-challenged mice using ovalbumin model SM Standley, YJ Kwon, N Murthy, J Kunisawa, N Shastri, SJ Guillaudeu, ... Bioconjugate chemistry 15 (6), 1281-1288, 2004 | 108 | 2004 |
| Directed antigen presentation using polymeric microparticulate carriers degradable at lysosomal pH for controlled immune responses YJ Kwon, SM Standley, AP Goodwin, ER Gillies, JMJ Fréchet Molecular pharmaceutics 2 (1), 83-91, 2005 | 92 | 2005 |
| Cancer cell-derived, drug-loaded nanovesicles induced by sulfhydryl-blocking for effective and safe cancer therapy D Ingato, JA Edson, M Zakharian, YJ Kwon ACS nano 12 (9), 9568-9577, 2018 | 91 | 2018 |
| Controlled cytoplasmic and nuclear localization of plasmid DNA and siRNA by differentially tailored polyethylenimine MS Shim, YJ Kwon Journal of Controlled Release 133 (3), 206-213, 2009 | 90 | 2009 |
| Synthetically designed peptide-based biomaterials with stimuli-responsive and membrane-active properties for biomedical applications S Wong, MS Shim, YJ Kwon Journal of Materials Chemistry B 2 (6), 595-615, 2014 | 87 | 2014 |
Julius A. Edson, Ph.D.University of California, IrvineE-mail megerősítve itt: uci.edu